Plasma; ELISA and/or LUMINEX screening for SARS-CoV-2 N, S, RBD IgG and IgA antibodies among other common viral infections such as the common human CoVs (OC43, LN63, 229E, and HKU1) influenza, EBV, and CMV. This evidence concerns the gene CD79A and viral infectious disease.